DOCTORS'
Medical Case Studies
DOCTORS'
Medical Case Studies
Tysabri
Natalizumab
Natalizumab is a humanized monoclonal antibody against the cellular adhesion molecule α4-integrin. Natalizumab is used in the treatment of multiple sclerosis and Crohn's disease. It is co-marketed by Biogen Idec and Élan as Tysabri, and was previously named Antegren. Natalizumab is administered by intravenous infusion every 28 days. The drug is believed to work by reducing the ability of inflammatory immune cells to attach to and pass through the cell layers lining the intestines and blood-brain barrier. Natalizumab has proven effective in treating the symptoms of both diseases, preventing relapse, vision loss, cognitive decline and significantly improving quality of life in people with multiple sclerosis, as well as increasing rates of remission and preventing relapse in Crohn's disease...
Tysabri - List of case studies
- Multiple Sclerosis_2
-
and shortness of breath. Natalizumab (Tysabri) . This drug is administered intravenously once a ... Avonex, Rebif, Glatiramer, Copaxone, Natalizumab, Tysabri, Mitoxantrone, Novantrone, Cyclophosphamide, Cytoxan, ... Avonex, Rebif, Glatiramer, Copaxone, Natalizumab, Tysabri, Mitoxantrone, Novantrone, Cyclophosphamide, Cytoxan, ...
- Drugs
-
wilfordii Tubacin Tumour necrosis factor Tysabri U Ultrashort GnTH-agonist-GnRH antagonist Unconjugated ...
- Autoimmune hepatitis/cholangitis in patient with Crohn’s disease.
-
remicade. Anti integrin approach with natalizumab (Tysabri) is also approve for anti TNF failures. Anti IL12/23 antibody ... (Budesonide) , Remicade, Humira , Cimzia, natalizumab (Tysabri), Ustekinumab Anatomy: ...